Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCMP

Sucampo Pharmaceuticals, Inc. (delisted) (SCMP)

Sucampo Pharmaceuticals, Inc. (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCMP
DateTimeSourceHeadlineSymbolCompany
03/05/20144:02PMGlobeNewswire Inc.Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH ConferenceNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
03/05/20146:06AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
03/05/20146:06AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
03/04/201410:00AMGlobeNewswire Inc.Sucampo and National Cherry Blossom Festival Announce Sucampo as Host and 'Step Into Spring' Program Sponsor for 2014NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/26/20144:02PMGlobeNewswire Inc.Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating ResultsNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/21/20143:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/19/201411:29AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/14/20148:18AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/13/20144:11PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20142:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20142:28PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20142:09PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20142:08PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20142:06PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20146:45AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/12/20146:45AMGlobeNewswire Inc.Sucampo Pharmaceuticals Announces Fourth Quarter and Full Year 2013 Results and Operating Highlights Teleconference and Webca...NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/10/20144:02PMGlobeNewswire Inc.Sucampo Names Peter Greenleaf Chief Executive OfficerNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/06/20146:45AMGlobeNewswire Inc.All Physicians in Switzerland Are Now Able to Prescribe Sucampo's AMITIZA(R) for Chronic Idiopathic ConstipationNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/05/20146:45AMGlobeNewswire Inc.Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Leerink Global Healthcare ConferenceNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
12/26/20135:00PMZacksSucampo Reports Data - Analyst BlogNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
12/23/20136:45AMGlobeNewswire Inc.Sucampo Reports Results from Phase 2a Study of Intravenous Ion Channel Activator for Lumbar Spinal StenosisNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
12/17/20136:45AMGlobeNewswire Inc.Sucampo and Takeda Initiate Global Pivotal Phase 3 Program of Lubiprostone in Pediatric Functional ConstipationNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
12/04/20138:57AMZacksGalectin Therapeutics (GALT) in Focus: Stock Moves Up 13.2% - Tale of the TapeNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/19/201312:33PMZacksPrescription for Profit - Zacks Industry Rank AnalysisNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/19/201312:33PMZacksPrescription for Profit - Zacks Industry Rank AnalysisNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/13/20136:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/08/201311:35AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/06/20136:45AMGlobeNewswire Inc.Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2013 Credit Suisse Healthcare ConferenceNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/05/20134:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
11/05/20134:02PMGlobeNewswire Inc.Sucampo Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2013 Financial and Operating ResultsNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:SCMP